Fierce Biotech May 8, 2024
American Clinical Research Services has purchased Elixia, a clinical trial network that specializes in studies involving research subjects with challenging metabolic conditions. The companies announced the deal in a May 8 press release. Financial terms were not disclosed.
The acquisition will integrate Elixia’s multistate, multispecialty operations into American Clinical’s portfolio—which was previously limited to California and Texas—and brings the CRO’s total number of sites to 12. Elixia runs trials in Missouri, Michigan, Massachusetts and Florida, including trials at a 40-bed facility in Tampa dedicated to phase 1 studies involving...
Today's Sponsors
Today's Sponsor